SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-4.4%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.13B
AUM Growth
+$1.13B
(-0.41%)
Cap. Flow
+$24.4M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
116
New
25
Increased
31
Reduced
26
Closed
23
Top Buys
| 1 |
Terns Pharmaceuticals
TERN
|
$33.7M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$32.4M |
| 3 |
Praxis Precision Medicines
PRAX
|
$20.5M |
| 4 |
Nurix Therapeutics
NRIX
|
$19.6M |
| 5 |
Enliven Therapeutics
ELVN
|
$18M |
Top Sells
| 1 |
Rigel Pharmaceuticals
RIGL
|
$67.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$47.1M |
| 3 |
United Therapeutics
UTHR
|
$37.7M |
| 4 |
GeneDx Holdings
WGS
|
$18.2M |
| 5 |
HCA Healthcare
HCA
|
$17.2M |
Sector Composition
| 1 | Healthcare | 99.14% |
| 2 | Consumer Staples | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVRx
CVRX
$205M
| $7.04M | 0.62% | 587,098 +538,598 | +1,111% | +$6.46M |
|
52
Insmed
INSM
$28.8B
| $6.87M | 0.61% | 102,472 -147,528 | -59% | -$9.88M |
|
53
Hims & Hers Health
HIMS
$9.57B
| $6.72M | 0.59% | +333,000 | New | +$6.72M |
|
|
THTX
54
Theratechnologies
THTX
$149M
| $6.72M | 0.59% | 4,801,376 | – | – |
|
55
Immunovant
IMVT
$2.56B
| $6.65M | 0.59% | 251,900 -12,750 | -5% | -$337K |
|
56
Adaptive Biotechnologies
ADPT
$2.01B
| $6.23M | 0.55% | +1,720,000 | New | +$6.23M |
|
57
Applied Therapeutics
APLT
$71M
| $5.93M | 0.52% | 1,269,714 -295,202 | -19% | -$1.38M |
|
58
Globus Medical
GMED
$8.27B
| $5.89M | 0.52% | +86,000 | New | +$5.89M |
|
59
Jazz Pharmaceuticals
JAZZ
$7.75B
| $5.76M | 0.51% | +53,935 | New | +$5.76M |
|
60
BioAtla
BCAB
$26.7M
| $5.34M | 0.47% | 3,901,314 -163,883 | -4% | -$225K |
|
61
Erasca
ERAS
$445M
| $5.1M | 0.45% | +2,162,162 | New | +$5.1M |
|
62
Verastem
VSTM
$569M
| $4.95M | 0.44% | 1,661,297 +120,663 | +8% | +$360K |
|
|
MREO
63
Mereo BioPharma
MREO
$272M
| $4.49M | 0.4% | 1,246,953 -1,370,000 | -52% | -$4.93M |
|
64
iRadimed
IRMD
$921M
| $4.48M | 0.4% | 102,067 -259,563 | -72% | -$11.4M |
|
65
Viridian Therapeutics
VRDN
$1.5B
| $4.42M | 0.39% | 340,000 | – | – |
|
66
Exact Sciences
EXAS
$8.98B
| $3.87M | 0.34% | +91,611 | New | +$3.87M |
|
67
Insulet
PODD
$23.9B
| $3.79M | 0.33% | +18,800 | New | +$3.79M |
|
68
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $3.73M | 0.33% | +200,000 | New | +$3.73M |
|
69
InspireMD
NSPR
$102M
| $3.44M | 0.3% | 1,378,128 | – | – |
|
70
CalciMedica
CALC
$37.7M
| $3.1M | 0.27% | 783,904 | – | – |
|
71
The Beauty Health Co
SKIN
$264M
| $3.08M | 0.27% | 1,604,718 +1,434,718 | +844% | +$2.75M |
|
72
Sanofi
SNY
$121B
| $3.03M | 0.27% | +62,500 | New | +$3.03M |
|
73
Fate Therapeutics
FATE
$120M
| $2.85M | 0.25% | 870,000 | – | – |
|
74
X4 Pharmaceuticals
XFOR
$84.2M
| $2.35M | 0.21% | 4,051,000 -528,926 | -12% | -$307K |
|
75
Olema Pharmaceuticals
OLMA
$375M
| $2.34M | 0.21% | 216,500 -441,500 | -67% | -$4.78M |
|